Mouwasat Medical Services Company (4002.SR)
SAR 88.2
(-0.34%)
SAR 88.2
(-0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 813.78 Million | 707.32 Million | 682.83 Million | 482.52 Million | 641.1 Million | 385.83 Million |
| Net Income | 688.38 Million | 632.68 Million | 632.19 Million | 576.86 Million | 462.23 Million | 408.69 Million |
| Depreciation & Amortization | 223.47 Million | 188.54 Million | 157.49 Million | 148.34 Million | 144.94 Million | 109.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -214.68 Million | -124.91 Million | -72.89 Million | -247 Million | 45.96 Million | -129.01 Million |
| Other non-cash items | 116.6 Million | 11 Million | -33.95 Million | 4.31 Million | -12.03 Million | -3.63 Million |
| Investing Cash Flow | -474.7 Million | -371.19 Million | -445.7 Million | -318.96 Million | -404.51 Million | -409.38 Million |
| Investments in PPE | -286.53 Million | -298.67 Million | -330.22 Million | -233.72 Million | -270.58 Million | -311.86 Million |
| Acquisitions | 791.3 Thousand | -101.17 Million | 5.47 Million | 673.27 Thousand | 687.52 Thousand | -15.26 Million |
| Investment purchases | -11.79 Million | -11 Million | -17 Million | -673.27 Thousand | -55 Million | - |
| Sales/Maturities of investments | 11 Million | 101.17 Million | -5.47 Million | 7 Million | -687.52 Thousand | 5 Million |
| Other Investing Activities | -188.16 Million | -61.52 Million | -98.48 Million | -92.24 Million | -78.92 Million | -102.51 Million |
| Financing Cash Flow | -433.9 Million | -349.12 Million | -240.41 Million | -208.03 Million | -162.14 Million | -48.06 Million |
| Debt repayment | -276.38 Million | -233.86 Million | -184.21 Million | -111.66 Million | -79.19 Million | -105.06 Million |
| Dividends payments | -300 Million | -275 Million | -250 Million | -200 Million | -175 Million | -150 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 142.47 Million | 159.74 Million | 193.8 Million | 103.62 Million | 92.04 Million | 207 Million |
| Accounts receivables | -232.07 Million | -260.76 Million | -106.94 Million | -199.9 Million | -5.93 Million | -298.02 Million |
| Accounts payables | 22.77 Million | 27.27 Million | 20.93 Million | -13.88 Million | 30.1 Million | 52.75 Million |
| Inventory | 6.22 Million | -16.49 Million | -1.31 Million | -20.25 Million | -25.57 Million | -17.95 Million |
| Other working capital | -11.59 Million | 125.07 Million | 14.41 Million | -12.95 Million | 47.37 Million | -111.06 Million |
| Cash at beginning of period | 143.87 Million | 156.86 Million | 160.15 Million | 204.62 Million | 130.17 Million | 201.79 Million |
| Cash at end of period | 49.04 Million | 143.87 Million | 156.86 Million | 160.15 Million | 204.62 Million | 130.17 Million |
| Capital Expenditure | -286.53 Million | -298.67 Million | -330.22 Million | -233.72 Million | -270.58 Million | -311.86 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -94.82 Million | -12.99 Million | -3.28 Million | -44.47 Million | 74.44 Million | -71.61 Million |
| Free Cash Flow | 527.24 Million | 408.65 Million | 352.61 Million | 248.8 Million | 370.51 Million | 73.96 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 158.86 Million | 171.58 Million | 688.38 Million | 192.51 Million | 163.54 Million | 157.6 Million |
| Depreciation & Amortization | 59.05 Million | 58.39 Million | 223.47 Million | 57.64 Million | 56.14 Million | 55.12 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 88.82 Million | -34.35 Million | -214.68 Million | -188.51 Million | -40.7 Million | 85.46 Million |
| Other non-cash items | 5.49 Million | 304.48 Million | 116.6 Million | 84.9 Million | 9.25 Million | -8.54 Million |
| Investing Cash Flow | 103.85 Million | -235.27 Million | -474.7 Million | -123.36 Million | -292.1 Million | 47.73 Million |
| Investments in PPE | -99.46 Million | -123.62 Million | -286.53 Million | -118.83 Million | -69.09 Million | -55.69 Million |
| Acquisitions | 18.74 Thousand | 348.69 Thousand | 791.3 Thousand | 697.42 Thousand | -59.03 Thousand | 67.95 Thousand |
| Investment purchases | 112 Million | -112 Million | -11.79 Million | 9.3 Million | 30.05 Million | 64 Million |
| Sales/Maturities of investments | 100 Million | - | 11 Million | -10 Million | -30 Million | 51 Million |
| Other Investing Activities | 2.69 Million | -21.45 Million | -188.16 Million | -4.53 Million | -223 Million | -11.63 Million |
| Financing Cash Flow | -354.06 Million | 66.17 Million | -433.9 Million | -81.19 Million | 24.39 Million | -320.45 Million |
| Debt repayment | -25.33 Million | -67.98 Million | -276.38 Million | -81.19 Million | -74.53 Million | -64 Million |
| Dividends payments | -350 Million | - | -300 Million | - | - | -300 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -354.06 Million | -1.00 | 142.47 Million | -81.19 Million | 98.92 Million | 43.55 Million |
| Accounts receivables | 142.42 Million | -142.89 Million | -232.07 Million | -123.87 Million | -114.32 Million | 108.38 Million |
| Accounts payables | 28.76 Million | 35.57 Million | 22.77 Million | -8.5 Million | -11.85 Million | 49.47 Million |
| Inventory | 5.21 Million | -31.6 Million | 6.22 Million | 23.15 Million | -7.71 Million | -20.63 Million |
| Other working capital | -108.58 Million | 104.57 Million | -11.59 Million | -79.29 Million | 93.18 Million | -51.76 Million |
| Cash at beginning of period | 124.34 Million | 49.04 Million | 143.87 Million | 107.05 Million | 186.53 Million | 169.61 Million |
| Cash at end of period | 170.59 Million | 124.34 Million | 49.04 Million | 49.04 Million | 107.05 Million | 186.53 Million |
| Capital Expenditure | -99.46 Million | -123.62 Million | -286.53 Million | -118.83 Million | -69.09 Million | -55.69 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 46.24 Million | 75.29 Million | -94.82 Million | -58 Million | -79.48 Million | 16.92 Million |
| Free Cash Flow | 196.98 Million | 120.77 Million | 527.24 Million | 27.72 Million | 119.12 Million | 233.94 Million |
5211
300205
5285
FR
GXYEF
ABG